Publications by authors named "K Muro"

Claim this Profile
R
Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan.
H Kawakami, K Uchino, W Hashimoto, K Muro

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers.
K Muro, K Chin, S B Maron, F S Braiteh, S Mitani

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancer.
Chie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, Hirokazu Shoji, Kai Tsugaru, Kei Muro

Cancer Immunol Immunother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral SNCA cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.
Chie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, Hirokazu Shoji, Kai Tsugaru, Kei Muro

Discov Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Realizing Equitable Precision Oncology via Remote Participation: Japan's First Fully Decentralized Trial (WJOG15221M).
Hiroya Taniguchi, Toshiki Masuishi, Tomoki Sakakida, Takatsugu Ogata, Nobumasa Mizuno, Kei Muro

Cancer Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis